Accumulating evidence indicates that the gut microbiota can promote or inhibit colonic
inflammation and carcinogenesis. Promotion of beneficial gut bacteria is considered a …

Oral mRNA delivery is a promising yet understudied approach for treating inflammatory
bowel disease (IBD). Inspired by the colon-targeting ability of ginger-derived nanoparticles …

The mucosa of the gastrointestinal tract, eyes, nose, lungs, cervix and vagina is lined by
epithelium interspersed with mucus-secreting goblet cells, all of which contribute to their …

Inflammatory bowel disease (IBD) represents a group of idiopathic chronic inflammatory
intestinal conditions associated with various areas of the GI tract, including two types of …

Ulcerative colitis (UC) is an inflammatory bowel disease with increasing incidence in the
world, especially in developing countries. Although knowledge of its pathogenesis has …

Previous studies have suggested that the Lactobacillus plantarum bacteria strain could be
effective in ulcerative colitis (UC) management. However, its effects are strain-specific and …

Context: Spirulina platensis (SP) is used as a source of protein and vitamin supplement in
humans without any significant side-effects. Dunaliella salina (DS) is also regarded as one …

Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …

Enteric inflammation models can help researchers' study methods to improve health and
performance and evaluate various growth promoters and dietary formulations targeted to …

Mucoadhesive drug delivery systems stick to mucosal tissues and prolong the local retention
time of drugs. Since the colon is covered by a mucosal layer, mucoadhesive rectal …